Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunctionZhen Wang, Jiong Li, Jing Hu et al.|Signal Transduction and Targeted Therapy|2022Cited by 61
Interleukin‐38 promotes skin tumorigenesis in an IL‐1Rrp2‐dependent mannerHong Zhou, Jiong Li, Qixiang Zhao et al.|EMBO Reports|2022Cited by 14
Interleukin‐37 promotes DMBA/TPA skin cancer through SIGIRR‐mediated inhibition of glycolysis in CD103<sup>+</sup>DC cellsFanlian Zeng, Jiong Li, Xiaoyan Wang et al.|MedComm|2023Cited by 13